Results for tag: "Igg4 Related Disease Drug"

The IgG4 Related Disease Drug market is a subset of the Immune Disorders Drugs market. It is composed of drugs used to treat IgG4-related diseases, a group of autoimmune disorders characterized by elevated levels of IgG4 antibodies. These drugs are used to reduce inflammation, suppress the immune system, and reduce the production of IgG4 antibodies. Commonly used drugs include corticosteroids, immunosuppressants, and biologics. The IgG4 Related Disease Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more